Supreme Court Rejects Trump Bid to Limit Trans Inmate Care

WHO:

CNN - The Supreme Court, President Donald Trump, the Trump administration, the Bureau of Prisons (BOP), three prisoners challenging the policy, and the American Civil Liberties Union were involved in the dispute.

CBS News - The Supreme Court rejected the emergency appeal; Justices Samuel Alito and Clarence Thomas said they would have allowed the administration to enforce the policy.

CBS News - The challengers were a transgender woman and two transgender men in federal prisons. They sued on behalf of incarcerated people diagnosed with gender dysphoria.

CBS News - Solicitor General D. John Sauer argued for the Trump administration. U.S. District Judge Royce Lamberth blocked the policy; he was appointed by President Ronald Reagan.

WHAT:

CNN - The Supreme Court’s ruling was described as a rare win for transgender rights at the conservative high court.

CBS News - The Supreme Court’s order was unsigned.

CNN - The Supreme Court’s order was notable because the case had been fully briefed and ready for a decision for almost two weeks.

CNN - The Supreme Court has also allowed the administration to bar transgender people from military service, upheld a policy requiring passport sex designations to match sex assigned at birth, and upheld state laws prohibiting transgender athletes from competing on girls’ sports teams.

CNN - The Supreme Court blocked the administration from suspending hormone therapy and other gender-affirming care for transgender people in federal prisons. Its one-sentence order gave no explanation.

CBS News - The Court left in place a lower-court order blocking the BOP policy and rejected the Justice Department’s request to freeze that order and reinstate the policy.

CBS News - The policy would end surgery, hormone therapy and social accommodations for inmates diagnosed with gender dysphoria, including breast padding, binders, wigs and makeup. It allowed hormone-treatment tapering before discontinuation and retained psychotherapy and psychiatry services.

CNN - The administration said prior treatments and accommodations raised security and prison-administration concerns that outweighed their “limited benefits.” The ACLU said BOP had not identified a security incident related to the treatment in 30 years.

CBS News - Plaintiffs said BOP had provided hormone treatment since 1992 and the policy could end treatment for nearly 1,000 inmates. They argued BOP provided no evidence that the restricted treatments were ineffective or harmful.

CBS News - The plaintiffs said psychotherapy was “backed by no evidence” as a treatment for gender dysphoria, and that psychotropic medication treated co-existing conditions rather than gender dysphoria.

WHERE:

CBS News - The affected inmates were in federal prisons; the district court and appeals court proceedings took place in Washington, DC.

WHEN:

CNN - The Supreme Court issued its order on Wednesday; the DC Circuit had blocked the policy in an order last month.

CBS News - Trump issued the executive order last year; BOP introduced its policy in February. Judge Lamberth blocked enforcement in June and continued the injunction in August. The appeals court later declined to lift it.

WHY:

CBS News - President Trump’s executive order barred federal funds from being used for medical procedures or treatments for transgender inmates in Bureau of Prisons custody.

CBS News - Judge Royce Lamberth wrote, “The court does not wade into the culture war being waged against transgender individuals.”

CBS News - The Trump administration said the policy was needed to “maintain institutional security” and to reflect “the latest scientific information” and correctional security and administrative concerns.

CBS News - Judge Lamberth said the government violated federal law by restricting gender-affirming care for inmates with gender dysphoria.

HOW:

CBS News - The Supreme Court’s order was unsigned and consisted of one line.

CBS News - The Bureau of Prisons’ policy memo said the changes were intended to align treatment with “the latest scientific information,” tailor medical care to inmates’ needs, and account for security and administrative concerns.

CBS News - Solicitor General D. John Sauer argued that the district court ruling “prevents the application of the Executive’s chosen policy” on a broad basis.

CNN - The DC Circuit found the BOP had not “adequately” considered its experience under its prior policy and said the policy was likely arbitrary and capricious.

CBS News - A three-judge DC Circuit panel ruled 2–1 that BOP had not adequately considered its prior experience and had not shown it was likely to succeed on the merits.

(UPDATED October 21, 2026 21:16 UTC)

The Supreme Court has blocked the Trump administration from ending hormone therapy and other gender-affirming care for transgender people in federal prisons. In an unsigned, one-line order, the justices rejected the Justice Department’s emergency request to reinstate the policy, leaving a lower-court injunction in place. Justices Samuel Alito and Clarence Thomas said they would have allowed the policy to take effect. The Bureau of Prisons plan would have ended surgery, hormone treatment and accommodations such as binders, wigs and makeup for inmates diagnosed with gender dysphoria, while retaining mental health services. The administration argued the changes were needed for security and to reflect current science. Three prisoners, including a transgender woman and two transgender men, challenged the policy. Lower courts found the bureau had not adequately considered its prior experience or justified the restrictions.

(UPDATED October 21, 2026 19:15 UTC)

The Supreme Court has refused to let the Trump administration end gender-affirming care for transgender people in federal prisons, leaving a lower-court block in place. The unsigned, one-sentence order gave no explanation, and Justices Samuel Alito and Clarence Thomas said they would have allowed the policy to take effect. The Bureau of Prisons plan would have ended surgery, hormone therapy and accommodations such as binders and wigs for inmates diagnosed with gender dysphoria, while permitting hormone treatment to be tapered and keeping mental-health services. The administration argued the restrictions served prison security and reflected current scientific information. Three prisoners challenged the policy, saying the Bureau had offered no evidence the treatments were harmful or ineffective. A federal judge found the government had violated the law, and an appeals court said the Bureau had not adequately considered its prior experience. The American Civil Liberties Union represented the challengers.

(UPDATED October 21, 2026 18:11 UTC)

The Supreme Court has blocked the Trump administration from ending gender-affirming care and accommodations for transgender people in federal prisons. The justices rejected an emergency appeal, leaving in place a lower-court order that prevents the Bureau of Prisons from enforcing its policy. The policy would have ended surgery, hormone therapy and accommodations such as binders, wigs and makeup, while retaining mental health services. Three prisoners—a transgender woman and two transgender men—challenged the policy on behalf of incarcerated people diagnosed with gender dysphoria. The administration argued that security and prison-management concerns justified the restrictions, but a federal judge found the government had violated the law. A federal appeals court also concluded the bureau had not adequately considered its experience under the previous policy. The Supreme Court gave no explanation; Justices Samuel Alito and Clarence Thomas said they would have let the policy take effect.

(UPDATED October 21, 2026 17:19 UTC)

The Supreme Court has blocked the Trump administration from ending gender-affirming care for transgender people in federal prisons, leaving a lower-court order in place. The justices gave no explanation, while Justices Samuel Alito and Clarence Thomas said they would have let the policy take effect. The Bureau of Prisons policy would end surgery, hormone therapy and social accommodations, though it allowed hormone treatment to be tapered and retained mental health services. Three prisoners—a transgender woman and two transgender men—challenged the policy on behalf of incarcerated people diagnosed with gender dysphoria. They argued the Bureau offered no evidence the restricted treatments were ineffective or harmful. The administration said the restrictions addressed prison security and administrative concerns. Lower courts found the Bureau had not adequately considered its experience under the previous policy, and a district judge ruled the restrictions violated federal law.